Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor α expression via activation of nuclear factor-κB

Gut

Volumn 55, Issue 12, 2006, Pages 1801-1808

  Sato, Y ^a,a   Kato, J ^a   Takimoto, R ^a   Takada, K ^a   Kawano, Y ^a   Miyanishi, K ^a   Kobune, M ^a   Takayama, T ^a   Matunaga, T ^a   Niitsu, Y ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CORE PROTEIN; CYTOKINE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SN 50; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA ANTIBODY;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE, TUMOR; ENZYME ACTIVATION; HEPACIVIRUS; HUMANS; LIVER NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; NF-KAPPA B; PEPTIDES; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR ALPHA; VIRAL CORE PROTEINS;

EID: 33845436329     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.070417     Document Type: Article

References (35)

1. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997;26:34S-8S.
2. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
3. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990;87:9524-8.
4. Hijikata M, Kato N, Ootsuyama Y, et al. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 1991;88:5547-51.
5. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991;88:2451-5.
6. Hijikata M, Mizushima H, Tanji Y, et al. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci USA 1993;90:10773-7.
7. Moriya K, Fujie H, Shintani Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7.
8. Moriya K, Nakagawa K, Santa T, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepotocarcinogenesis. Cancer Res 2001;61:4365-70.
9. Marusawa H, Hijikata M, Chiba T, et al. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 1999;73:4713-20.
10. You LR, Chen CM, Lee YH. Hepatitis C virus core protein enhances NF-kappa B signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol 1999;73:1672-81.
11. Kato N, Yoshida H, Kioko Ono-Nita S, et al. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 2000;32:405-12.
12. Yoshida H, Kato N, Shiratori Y, et al. Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 2001;276:16399-405.
13. Chung YM, Park KJ, Choi SY, et al. Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta- dependent pathway. Biochem Biophys Res Commun 2001;284:15-19.
14. Giambartolomei S, Covone F, Levrero M, et al. Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the hepatitis C virus (HCV) core protein. Oncogene 2001;20:2606-10.
15. Erhardt A, Hassan M, Heintges T, et al. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002;292:272-84.
16. Tsutsumi T, Suzuki T, Moriya K, et al. Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Virology 2002;304:415-24.
17. Tsuhumi T, Suzuki T, Moriya K, et al. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 2003;38:820-8.
18. Derynck R, Goeddel DV, Ullrich A, et al. Synthesis of messenger RNAs far transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 1987;47:707-12.
19. Salomon DS, Kim N, Saeki T, et al. Transforming growth factor-alpha: an oncodevelopmental growth factor. Cancer Cells 1990;2:389-97.
20. Jhappan C, Stahle C, Harkins RN, et al. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990;61:1137-46.
21. Lee GH, Merlino G, Fausto N. Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res 1992;52:5162-70.
22. Tanaka S, Takenaka K, Matsumata T, et al. Hepatitis C virus replication is associated with expression of transforming growth factor-α and insulin-like growth factor-II in cirrhotic liver. Dig Dis Sci 1996;42:208-15.
23. Lin YZ, Yao SY, Veach RA, et al. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995;270:14255-8.
24. Pang L, Sawada T, Decker SJ, et al. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 1995;270:13585-8.
25. Yanagi M, St Claire M, Shapiro M, et al. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology 1998;244:161-72.
26. Takimoto R, El-Deiry WS. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 2000;19:1735-43.
27. Schreiber E, Matthias P, Muller MM, et al. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
28. Hagiwara S, Nakamura K, Hamada H, et al. Inhibition of type I procollagen production by tRNAVal CTE-HSP47 ribozyme. J Gene Med 2003;5:784-94.
29. Wang D, Shin TH, Kudlow JE. Transcription factor AP-2 controls transcription of the human transforming growth factor-alpha gene. J Biol Chem 1997;272:14244-50.
30. Wang D, Kudlow JE. Purification and characterization of TEF1, a transcription factor that controls the human transforming growth factor-alpha promoter. Biochim Biophys Acta 1999;1449:50-62.
31. Ghosh S, Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 1990;344:678-82.
32. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-66.
33. Shrivastava A, Manna SK, Ray R, et al. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol 1998;72:9722-8.
34. Zhu N, Khoshnan A, Schneider R, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998;72:3691-7.
35. Waris G, Livolsi A, Peyron JF, et al. Hepatitis C virus NS5A and subgenomic replicon activate NF-kB via tyrosine phosphorylation of IkB and its degradation by calpain protease. J Biol Chem 2003;278:40778-87.